Spanish-language cancer care support for breast or prostate radiation
Part of Cancer, Kidney & urinary, Skin clinical trials.
This study tests an educational and communication support program to help Spanish-speaking people stay on track with treatment when they’re getting radiation for non-spread (non-metastatic) breast or prostate cancer. It may help by improving understanding through interpreter-supported visits.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You speak Spanish and are Latinx (Mexican, Puerto Rican, Cuban, Dominican, or Central/South American ancestry)
- You have breast or prostate cancer that has not spread to other parts of the body
- Your diagnosis has been confirmed by pathology (tissue or biopsy testing)
- You are planning to get curative (aimed at cure) radiation to treat breast or prostate cancer
- You can take part in visits with a certified interpreter
- You are well enough for study activities (Karnofsky score 70 or higher)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a navigator program helps people from certain backgrounds complete their radiation therapy. If you have breast or prostate cancer and are scheduled for radiation, you may be able to join.
This study tests new educational materials about genetic testing for cancer patients. It aims to find the best ways to explain genetic testing to people from different backgrounds, especially Black, Latino, and non-Latino non-Black communities.
This study tests a psychotherapy (talking/support) intervention designed for Latino/Hispanic adults with stage III or IV solid tumor cancer. It uses Spanish-only questionnaires and interviews, and may help by addressing emotional distress during advanced cancer care.
This study tests a Spanish-language psychotherapy approach to help Latino adults with stage III or IV solid tumors (advanced cancer). It aims to see how well the therapy reduces distress and how patients and clinicians feel about it.
This study tests different ways of providing language interpretation during breast cancer or gastrointestinal cancer visits at MSK. It aims to improve communication for patients who prefer Spanish or Mandarin and have limited English proficiency.
This study offers a program to help people who have completed their main treatment for early-stage breast or prostate cancer. It focuses on follow-up and support during survivorship, and you are still eligible if you are on certain maintenance therapies like hormone therapy.
Hear when a new Breast Cancer Invasive trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.